EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling

Weixi Wang, Piaoping Kong, Kangle Feng, Chunhua Liu, Xubo Gong, Tao Sun, Xiuzhi Duan, Yiwen Sang, Yu Jiang, Xiang Li, Lingyu Zhang, Zhihua Tao iD und 1 weitere

Cancer Science · 2023

DOI: 10.1111/cas.15948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Weixi Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, MicroRNAs, Exosomes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Medical and Health Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the clinical benefits of androgen deprivation therapy, most patients with advanced androgen‐dependent prostate cancer (ADPC) eventually relapse and progress to lethal androgen‐independent prostate cancer (AIPC), also termed castration‐resistant prostate cancer (CRPC). MiRNAs can be packaged into exosomes (Exos) and shuttled between cells. However, the roles and mechanisms of exosomal miRNAs involved in CRPC progression have not yet been fully elucidated. Here, we find that miR‐222‐3p is elevated in AIPC cells, which results in remarkable enhancement of cell proliferation, migration, and invasion ability. Furthermore, Exos released by AIPC cells can be uptaken by ADPC cells, thus acclimating ADPC cells to progressing to more aggressive cell types in vitro and in vivo through exosomal transfer of miR‐222‐3p. Mechanistically, Exos‐miR‐222‐3p promoted ADPC cells transformed to AIPC‐like cells, at least in part, by activating mTOR signaling through targeting MIDN. Our results show that AIPC cells secrete Exos containing miRNA cargo. These cargos can be transferred to ADPC cells through paracrine mechanisms that have a strong impact on cellular functional remodeling. The current work underscores the great therapeutic potential of targeting Exo miRNAs, either as a single agent or combined with androgen receptor pathway inhibitors for CRPC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantMicroRNAsExosomesMaleHumansAndrogensAndrogen AntagonistsNeoplasm Recurrence, LocalCell ProliferationTOR Serine-Threonine KinasesCell Line, TumorAzo CompoundsImidazoles

Stichwörter der Autor:innen

androgen-independentexosomemTORmiRNAprostate cancer

Substanzen

AndrogensAndrogen AntagonistsMicroRNAsTOR Serine-Threonine KinasesVA 061Azo CompoundsImidazolesMIR222, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.
  • Department of Blood Transfusion, Zhejiang University School of Medicine Second Affiliated Hospital, Hangzhou, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

ORCID-Profile: Zhihua Tao, Weiwei Liu

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Medical and Health Science and Technology Project

Zitieren

APA

Wang, W., Kong, P., Feng, K., Liu, C., Gong, X., Sun, T., Duan, X., Sang, Y., Jiang, Y., Li, X., Zhang, L., Tao, Z., & Liu, W. (2023). Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling. Cancer Science. https://doi.org/10.1111/cas.15948

Vancouver

Wang W, Kong P, Feng K, Liu C, Gong X, Sun T, et al. Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling. Cancer Science. 2023. doi:10.1111/cas.15948

BibTeX
@article{Wang2023,
  author = {Wang, Weixi and Kong, Piaoping and Feng, Kangle and Liu, Chunhua and Gong, Xubo and Sun, Tao and Duan, Xiuzhi and Sang, Yiwen and Jiang, Yu and Li, Xiang and Zhang, Lingyu and Tao, Zhihua and Liu, Weiwei},
  title = {Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15948}
}
Kostenlos starten →